Your browser doesn't support javascript.
loading
Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancer.
Wolf, J; Helland, Å; Oh, I-J; Migliorino, M R; Dziadziuszko, R; Wrona, A; de Castro, J; Mazieres, J; Griesinger, F; Chlistalla, M; Cardona, A; Ruf, T; Trunzer, K; Smoljanovic, V; Novello, S.
Afiliación
  • Wolf J; Department I of Internal Medicine, Center for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Helland Å; Department of Cancer Genetics and Department of Oncology, Institute for Cancer Research, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Oh IJ; Department of Internal Medicine, Chonnam National University Medical School, Hwasun-gun Jeollanam-do, Republic of Korea.
  • Migliorino MR; Pulmonary Oncology Unit, Azienda Ospedaliera San Camillo Forlanini Hospital, Rome, Italy.
  • Dziadziuszko R; Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
  • Wrona A; Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
  • de Castro J; Department of Medical Oncology, La Paz University Hospital, IdiPAZ, Madrid, Spain.
  • Mazieres J; Department of Pneumology, Toulouse University Hospital, Paul Sabatier University, Toulouse, France.
  • Griesinger F; Department of Hematology and Oncology, Pius Hospital, University Medicine Oldenburg, Oldenburg, Germany.
  • Chlistalla M; F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Cardona A; F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Ruf T; F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Trunzer K; F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Smoljanovic V; F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Novello S; Department of Oncology, University of Turin, Orbassano, Italy. Electronic address: silvia.novello@unito.it.
ESMO Open ; 7(1): 100333, 2022 02.
Article en En | MEDLINE | ID: mdl-35042152
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article País de afiliación: Alemania